FDA clears Cardinal's Lymphoseek for pediatric use

By AuntMinnie.com staff writers

June 11, 2021 -- Cardinal Health announced that its Lymphoseek radiopharmaceutical has been approved for pediatric use by the U.S. Food and Drug Administration (FDA).

This comes after a clinical trial showed the radiopharmaceutical was deemed "safe and effective" for patients ages one month and older.

In addition to adult use, Lymphoseek provides lymph node identification in pediatric patients with melanoma, rhabdomyosarcoma (RMS), or other types of solid tumors. The approval will offer physicians, oncologists, and nuclear medicine specialists an option to enhance lymphatic mapping and guide sentinel lymph node biopsies in pediatric melanoma cases.

Copyright © 2021 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking